GE Healthcare, the medical diagnostics and imaging equipment arm of GE, is planning to position all its healthcare devices and equipment affordable in the domestic market.
At present, India imports 75 per cent of its medical technologies and devices making accessibility and affordability a challenge.
“The Indian market is different from many other markets in the world. The affordability of healthcare technologies is one of the important things, which will help the healthcare sector. We are committed towards it, and have plans to position all our products affordable and accessible,” said GE Healthcare President and CEO John Flannery.
As part of its new strategy, GE, launched first ‘Made in India’ Computed Tomography (CT Scan) system designed and manufactured by GE Healthcare in India.
The new product, ‘Revolution ACTs’, was developed by the company with an investment of around Rs.120 crore and is priced at less than Rs.1 crore.
With this launch, GE healthcare plans to tap hospitals and diagnostic centers in smaller towns.
Apart from focusing on the domestic market, it is planning to export the machines to other countries in Southeast Asia.